Lymphoma / Leukemia Program Clinical Trials
The following is a list of clinical trials with which this cancer care program is currently involved. Talk to your doctor to find out if a clinical trial is right for you.
Hodgkins Lymphoma Clinical Trials
An Open-Label, Randomized, Phase 3 Study Of Inotuzumab Ozogamicin Administered In Combination With Rituximab Compared To Defined Investigator's Choice Therapy In Subjects With Relapsed Or Refractory CD22-Positive Aggressive Non-Hodgkin Lymphoma Who Are Not Candidates For Intensive High-Dose Chemotherapy
Hodgkins Lymphoma
F11077
Lansigan
Blood and Marrow Stem Cell Transplant Outcomes Database
Hodgkins Lymphoma
D11197
Meehan
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Hodgkins Lymphoma
D0946
Bakitas
Health and Status and Quality of Life (QL) in Patients with Early Stage Hodgkin's Disease: A Companion Study to CALGB 9391
Hodgkins Lymphoma
C9497
Bengtson
Phase II Trial of Response-Adapted Therapy Based on Positron Emission Tomography (PET) for Bulky Stage I and Stage II Classical Hodgkin Lymphoma (HL)
Hodgkins Lymphoma
C50801
Bengtson
Protocol For A Research Database For Hematopoietic Stem Cell Transplantation And Marrow Toxic Injuries (NMDP #IRB-2002-0063)
Hodgkins Lymphoma
B0943
Lowrey
Protocol For A Research Sample Repository For Allogeneic Hematopoietic Stem Cell Transplantation And Marrow Toxic Injuries (NMDP #IRB-1991-0002)
Hodgkins Lymphoma
B0944
Lowrey
Randomized Trial of Subtotal Nodal Irradiation vs Doxorubicin plus Vinblastine and Subtotal Nodal Irradiation for Stage I-IIA Hodgkin's Disease, Phase III
Hodgkins Lymphoma
C9391
Bengtson
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Hodgkins Lymphoma
FED11061
Pace
Leukemia, Other Clinical Trials
A Dose-Ranging Study of Bendamustine and Rituximab in Chronic Lymphocytic Leukemia Patients with Comorbidities and/or Renal Dysfunction
Leukemia, Other
D13067
Danilov
A Phase 3, Randomized, Controlled, Double-Blind, Multinational Clinical Study of the Efficacy and Safety of Vosaroxin and Cytarabine Versus Placebo and Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (VALOR)
Leukemia, Other
F11030
Gautier
A Phase II Study of Dasatinib (Sprycel) (IND # 73969, NSC # 732517)as Primary Therapy Followed by Transplantation for Adults >=50 years with Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia by CALGB, ECOG, SWOG, and NCIC CTG
Leukemia, Other
C10701
Lowrey
A Phase III Randomized Study of Oral Sapacitabine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia
Leukemia, Other
F11057
Gautier
A Phase III Study of Risk Directed Therapy for Infants with Acute Lymphoblastic Leukemia (ALL): Randomization of Highest Risk Infants to Intensive Chemotherapy +/- FLT3 Inhibition
Leukemia, Other
AALL0631
Chaffee
A Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy
Leukemia, Other
F1037
Lansigan
Classification of Newly Diagnosed Acute Lymphoblastic Leukemia
Leukemia, Other
AALL08B1
Chaffee
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Leukemia, Other
D0946
Bakitas
Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia
Leukemia, Other
D11065
Lansigan
Phase II Study of Reduced-Intensity Allogeneic Stem Cell Transplant for High Risk Chronic Lymphocytic Leukemia (CLL)
Leukemia, Other
C100701
Lowrey
Phase II Study of the Addition of Azacitidine (IND #87574, NSC # 102816) to Reduced-Intensity Conditioning Allogeneic Transplantation for Myelodysplasia (MDS) and Older Patients with AML
Leukemia, Other
C100801
Lowrey
Protocol For A Research Database For Hematopoietic Stem Cell Transplantation And Marrow Toxic Injuries (NMDP #IRB-2002-0063)
Leukemia, Other
B0943
Lowrey
Protocol For A Research Sample Repository For Allogeneic Hematopoietic Stem Cell Transplantation And Marrow Toxic Injuries (NMDP #IRB-1991-0002)
Leukemia, Other
B0944
Lowrey
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Leukemia, Other
FED11061
Pace
Leukemia, not otherwise specified Clinical Trials
A Children's Oncology Group Protocol for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Specimens
Leukemia, not otherwise specified
AALL05B1
Chaffee
A Phase II Study Incorporating Sorafenib Into The Therapy of Patients ≥ 60 Years of Age With FLT3 Mutated Acute Myeloid Leukemia (AML)
Leukemia, not otherwise specified
C11001
Lowrey
A Study of Neurocognitive Function in Children Treated for ALL
Leukemia, not otherwise specified
AALL06N1
Chaffee
Assessment of Novel Molecular Markers in Acute Myeloid Leukemia
Leukemia, not otherwise specified
C20202
Gautier
Blood and Marrow Stem Cell Transplant Outcomes Database
Leukemia, not otherwise specified
D11197
Meehan
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Leukemia, not otherwise specified
C8461
Lowrey
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Leukemia, not otherwise specified
D0946
Bakitas
Protocol For A Research Database For Hematopoietic Stem Cell Transplantation And Marrow Toxic Injuries (NMDP #IRB-2002-0063)
Leukemia, not otherwise specified
B0943
Lowrey
Protocol For A Research Sample Repository For Allogeneic Hematopoietic Stem Cell Transplantation And Marrow Toxic Injuries (NMDP #IRB-1991-0002)
Leukemia, not otherwise specified
B0944
Lowrey
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Leukemia, not otherwise specified
FED11061
Pace
Umbrella Long-Term Follow Up Protocol
Leukemia, not otherwise specified
ALTE05N1
Chaffee
Lymphoid Leukemia Clinical Trials
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum
Lymphoid Leukemia
AALL1131
Chaffee
Blood and Marrow Stem Cell Transplant Outcomes Database
Lymphoid Leukemia
D11197
Meehan
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Lymphoid Leukemia
D0946
Bakitas
Intensified Methotrexate, Nelarabine (Compound 506U78; IND #52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia (ALL)or T-cell Lymphoblastic Lymphoma
Lymphoid Leukemia
AALL0434
Chaffee
Intergroup Trial for Children or Adolescents with B-cell Non-Hodgkin Lymphoma NHL or Mature B-cell Leukemia B- AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients.
Lymphoid Leukemia
ANHL1131
Chaffee
Protocol For A Research Database For Hematopoietic Stem Cell Transplantation And Marrow Toxic Injuries (NMDP #IRB-2002-0063)
Lymphoid Leukemia
B0943
Lowrey
Protocol For A Research Sample Repository For Allogeneic Hematopoietic Stem Cell Transplantation And Marrow Toxic Injuries (NMDP #IRB-1991-0002)
Lymphoid Leukemia
B0944
Lowrey
Protocol to Obtain Blood Samples for Chronic Lymphocytic Leukemia Research
Lymphoid Leukemia
D0905
Danilov
Randomized, Double-blind, Placebo-controlled Phase 3 Study of Ibrutinib, a Bruton`s Tyrosine Kinase (BTK) Inhibitor, in Combination with Bendamustine and Rituximab (BR)in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/SmallLymphocytic Lymphoma
Lymphoid Leukemia
F12144
Danilov
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Lymphoid Leukemia
FED11061
Pace
Multiple Myeloma Clinical Trials
A Prospective, Longitudinal, Observational Study in Newly Diagnosed Multiple Myeloma (MM) Patients to Assess the Relationship between Patient Outcomes,Treatment Regimens and Molecular Profiles (Protocol MMRF-11-01)
Multiple Myeloma
F12018
Meehan
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Multiple Myeloma
D0946
Bakitas
Protocol For A Research Database For Hematopoietic Stem Cell Transplantation And Marrow Toxic Injuries (NMDP #IRB-2002-0063)
Multiple Myeloma
B0943
Lowrey
Protocol For A Research Sample Repository For Allogeneic Hematopoietic Stem Cell Transplantation And Marrow Toxic Injuries (NMDP #IRB-1991-0002)
Multiple Myeloma
B0944
Lowrey
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Multiple Myeloma
FED11061
Pace
Mycosis Fungoides Clinical Trials
Blood and Marrow Stem Cell Transplant Outcomes Database
Mycosis Fungoides
D11197
Meehan
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Mycosis Fungoides
D0946
Bakitas
Protocol For A Research Database For Hematopoietic Stem Cell Transplantation And Marrow Toxic Injuries (NMDP #IRB-2002-0063)
Mycosis Fungoides
B0943
Lowrey
Protocol For A Research Sample Repository For Allogeneic Hematopoietic Stem Cell Transplantation And Marrow Toxic Injuries (NMDP #IRB-1991-0002)
Mycosis Fungoides
B0944
Lowrey
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Mycosis Fungoides
FED11061
Pace
Myeloid and Monocytic Leukemia Clinical Trials
A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND#114480; NSC# 681239, NSC# 724772) for Patients with High Allelic Ratio FLT3/ITD
Myeloid and Monocytic Leukemia
AAML1031
Chaffee
AAML08B1 Biology Study of Transient Myeloproliferative Disorder(TMD)in Children with Down Syndrome(DS)
Myeloid and Monocytic Leukemia
AAML08B1
Chaffee
ACCL0933 A Randomized Open-Label Trial of Caspofungin versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
Myeloid and Monocytic Leukemia
ACCL0933
Chaffee
Blood and Marrow Stem Cell Transplant Outcomes Database
Myeloid and Monocytic Leukemia
D11197
Meehan
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Myeloid and Monocytic Leukemia
D0946
Bakitas
Phase III, Multicenter, Randomized, Trial of CPX-351 (Cytarabine: Daunorubicin) Liposome Injection versus Cytarabine and Daunorubicin in Patients 60-75 Years of Age with Untreated High Risk (Secondary) AML. (Protocol cltr0310-301)
Myeloid and Monocytic Leukemia
F13089
Gautier
Protocol For A Research Database For Hematopoietic Stem Cell Transplantation And Marrow Toxic Injuries (NMDP #IRB-2002-0063)
Myeloid and Monocytic Leukemia
B0943
Lowrey
Protocol For A Research Sample Repository For Allogeneic Hematopoietic Stem Cell Transplantation And Marrow Toxic Injuries (NMDP #IRB-1991-0002)
Myeloid and Monocytic Leukemia
B0944
Lowrey
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Myeloid and Monocytic Leukemia
FED11061
Pace
Non-Hodgkins Lymphoma Clinical Trials
A Multicenter, Open Label, Phase II Study of Bendamustine and Rituximab followed by 90-yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma (Fol-BRITe study)
Non-Hodgkins Lymphoma
D1015
Lansigan
A Phase 3, Randomized, Two-Arm, Open-Label, Multicenter, International Trial of Alisertib (MLN8237) or Investigator`s Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma
Non-Hodgkins Lymphoma
F12097
Lansigan
A Randomized Phase 4 Study Comparing 2 Intravenous Temsirolimus (TEMSR) Regimens in Subjects With Relapsed, Refractory Mantle Cell Lymphoma
Non-Hodgkins Lymphoma
F11109
Bengtson
Blood and Marrow Stem Cell Transplant Outcomes Database
Non-Hodgkins Lymphoma
D11197
Meehan
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Non-Hodgkins Lymphoma
D0946
Bakitas
Intergroup Trial for Children or Adolescents with B-cell Non-Hodgkin Lymphoma NHL or Mature B-cell Leukemia B- AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients.
Non-Hodgkins Lymphoma
ANHL1131
Chaffee
Ofatumumab and Bortezomib for Patients With Low-grade B-cell Non-Hodgkin Lymphoma That Relapse After Rituximab
Non-Hodgkins Lymphoma
W11001
Lansigan
Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW-0761 (mogamulizumab) Versus Vorinostat in Subjects with Previously Treated Cutaneous T-Cell Lymphoma
Non-Hodgkins Lymphoma
F13057
Lansigan
Outcomes of Cutaneous T-cell Lymphoma and Chronic Graft-Versus-Host Disease Patients Treated with Extracorporeal Photopheresis
Non-Hodgkins Lymphoma
D11271
Lansigan
Outcomes of Patients with Newly Diagnosed Peripheral T-Cell Lymphoma Treated with Aggressive Chemotherapy
Non-Hodgkins Lymphoma
SNF11159
Lansigan
Prospective, Longitudinal, Multinational Registry of Patients With Newly Diagnosed Peripheral T-Cell Lymphoma
Non-Hodgkins Lymphoma
F1038
Lansigan
Protocol For A Research Database For Hematopoietic Stem Cell Transplantation And Marrow Toxic Injuries (NMDP #IRB-2002-0063)
Non-Hodgkins Lymphoma
B0943
Lowrey
Protocol For A Research Sample Repository For Allogeneic Hematopoietic Stem Cell Transplantation And Marrow Toxic Injuries (NMDP #IRB-1991-0002)
Non-Hodgkins Lymphoma
B0944
Lowrey
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Non-Hodgkins Lymphoma
FED11061
Pace
Other Hematopoietic Clinical Trials
Blood and Marrow Stem Cell Transplant Outcomes Database
Other Hematopoietic
D11197
Meehan
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Other Hematopoietic
D0946
Bakitas
Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation with Unrelated Donors
Other Hematopoietic
B0942
Meehan
Non-Myeloablative Chemotherapy Followed by HLA-Matched Related Allogeneic Stem Cell Transplantation for Hematologic Malignancies
Other Hematopoietic
D0345
Lowrey
Protocol For A Research Database For Hematopoietic Stem Cell Transplantation And Marrow Toxic Injuries (NMDP #IRB-2002-0063)
Other Hematopoietic
B0943
Lowrey
Protocol For A Research Sample Repository For Allogeneic Hematopoietic Stem Cell Transplantation And Marrow Toxic Injuries (NMDP #IRB-1991-0002)
Other Hematopoietic
B0944
Lowrey
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Other Hematopoietic
FED11061
Pace
